PRXL Key Statistics, Chart & Performance
The current stock price of PRXL is 88.08 null. In the past month the price increased by 0.22%. In the past year, price increased by 26.83%.
PRXL Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PRXL. When comparing the yearly performance of all stocks, PRXL is one of the better performing stocks in the market, outperforming 76.56% of all stocks.
PRXL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to PRXL. Both the profitability and the financial health of PRXL get a neutral evaluation. Nothing too spectacular is happening here.
PRXL Financial Highlights
Over the last trailing twelve months PRXL reported a non-GAAP Earnings per Share(EPS) of 2.06. The EPS decreased by -27.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.39% | ||
| ROA | 4.64% | ||
| ROE | 16.91% | ||
| Debt/Equity | 1.01 |
PRXL Forecast & Estimates
PRXL Ownership
About PRXL
Company Profile
Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.
Company Info
PAREXEL INTL CORP
195 WEST ST
WALTHAM MA 02451
CEO: Josef H. von Rickenbach
Phone: 781-487-9900
PAREXEL INTL CORP / PRXL FAQ
What does PRXL do?
Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.
What is the current price of PRXL stock?
The current stock price of PRXL is 88.08 null. The price decreased by -0.02% in the last trading session.
Does PAREXEL INTL CORP pay dividends?
PRXL does not pay a dividend.
What is the ChartMill rating of PAREXEL INTL CORP stock?
PRXL has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the PE ratio for PRXL stock?
The PE ratio for PAREXEL INTL CORP (PRXL) is 42.76. This is based on the reported non-GAAP earnings per share of 2.06 and the current share price of 88.08 null.
What is the market capitalization of PRXL stock?
PAREXEL INTL CORP (PRXL) has a market capitalization of 4.50B null. This makes PRXL a Mid Cap stock.